|
Combination strategies in myelodysplastic syndromes.
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis
|
Nov 2017
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
|
Jan 2015
|
Nat Commun.
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: challenges to improving patient and caregiver satisfaction"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: therapy and outlook"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients.
|
Jun 2013
|
Am J Hematol
|
aplastic anemia
|
|
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning
|
Nov 2016
|
Bone Marrow Transplant.
|
aplastic anemia
|
|
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes
|
Feb 2013
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes
|
Sep 2016
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
